Newsletter | January 13, 2022

01.13.22 -- How EU Biopharma Can Blaze The IDMP Data Standards Trail

Featured Editorial
Industry Insights
Technology Transfers: A Beginner’s Guide

You may have questions and knowledge gaps on technology transfers. This beginner’s guide covers the basics and the three key phases of technology transfers.

Is Your Biologic At Risk For Protein Aggregation? Part 2

The manufacture of sterile injectables is fraught with risk, especially when it comes to protein aggregation in biologics drugs. We offer steps you can take to help prevent aggregation.

Boost Performance With A Chromatography Resin Update

Although workhouse resins developed in the 1980s are still used in many processes worldwide, you could be missing out on better productivity and performance. Find an answer to the question, "How do I know which modern resin to use in my new projects?"

Tortoise Or Hare? How Biosafety Assurance Can Be Both Rapid And Purposeful Getting You To The Finish Line First

In this webinar, we will discuss how the advancement of bioprocessing and the rise of novel treatment modalities such as viral vectors, as well as the urgent need for COVID-19 treatments and vaccines have driven the industry to adopt rapid alternatives. By illustrating the reasons behind the move to faster methods and discussing the wider benefits these can bring we hope to do our bit to drive change within this change-resistant environment and help our customers win the race to market.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.